PKM2 methylation reversibly shifts the metabolic balance in breast cancer cells from oxidative phosphorylation to aerobic glycolysis, whereas inhibition of PKM2 methylation disrupts this intricate balance in cancer cells and suppresses breast cancer cell proliferation, migration, and metastasis (Liu et al., 2017). The gene discussed is PKM; the disease is breast carcinoma.